![]() Sensus Healthcare Sensus Healthcare is focused on developing proven non-melanoma skin cancer solutions. | ![]() Berry Oncology Berry Oncology is a company that develops medical technology intended to improve cancer prevention and tumor diagnosis. | ![]() Berry Genomics Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications, primarily in genetic testing and oncology testing. | |||
Founding Date | Founding Date 2014 | Founding Date 2010 | Founding Date 2017 | Founding Date N/A | Founding Date 2010 |
Type | Type Subsidiary | Type Public | Type Private | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Singapore, SG HQ | Locations Boca Raton, US HQ Giv'atayim, IL | Locations HQ | Locations London, GB HQ | Locations CN HQ |
Employees | Employees 18 | Employees 5310% increase | Employees N/A | Employees 2751% increase | Employees 1,402 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 113.9 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 460.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $27.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥1b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $15.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥572.9m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit $11.9m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit ¥494m (FY, 2024) |
Net income | Net income N/A | Net income ($7.7m) (FY, 2025) | Net income N/A | Net income N/A | Net income (¥188.2m) (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 2.5m | Total funding raised $ 1.4m | Total funding raised $ 337.9m | Total funding raised N/A | Total funding raised $ 145.7m |

Sensus Healthcare is focused on developing proven non-melanoma skin cancer solutions.
View company
Berry Oncology is a company that develops medical technology intended to improve cancer prevention and tumor diagnosis.
View companyNovartis UK is a developer, manufacturer, and marketer of medicines and devices.
View company
Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications, primarily in genetic testing and oncology testing.
View company